Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer

Gut

Volumn 55, Issue 7, 2006, Pages 1007-1011

  Furukawa, H ^a   Ikuma, H ^a   Seki, A ^a   Yokoe, K ^a   Yuen, S ^a   Aramaki, T ^a   Yamaguchi, S ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE; MALE; METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED; WHOLE BODY IMAGING;

EID: 33745498411     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.076273     Document Type: Article

References (29)

1. Nomura K, Sobue T, Honma I, et al. Mortality from malignant neoplasms by age group and sex in Japan. In: The editorial board of the cancer statistics in Japan. Cancer statistics in Japan 2003. Tokyo: Foundation for Promotion of Cancer Research, 2003:40-1.
2. Adam U, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in ttie local recurrence of rectal cancer. Lancet 1994;344:707-11.
3. de Haas-Kock DF, Baeten CG, Jager JJ, et al. Prognostic significance of radial margins of clearance of rectal cancer. Br J Surg 1996;83:781-5.
4. Hu H, He HD, Foley WD, et al. Four multidetector-row helical CT: image quality and volume coverage speed. Radiology 2000;215:55-62.
5. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-5.
6. Flier JS, Mueckler MM, Usher P, et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987;235:1492-5.
7. Topol B, Flamen P, Aerts R, et al. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol 2001;27:175-9.
8. Arulampalam T, Costa D, Visvikis D, et al. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 2001;28:1758-65.
9. Delbeke D, Vitola JV, Sandler MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-201.
10. Flamen P, Stroobants S, Van Cutsem E, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose in recurrent colorectal cancer. J Clin Oncol 1999;17:894-901.
11. Johnson K, Bakhsh A, Young D, et al. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 2001;44:354-7.
12. Lai DT, Fulham M, Stephen MS, et al. The role of whole-body positron emission tomography with [18F]fluorodeoxy-glucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996;131:703-7.
13. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison positron emission tomography and computed tomography. Ann Surg Oncol 1997;4:613-20.
14. Huebner PH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-89.
15. Gupta NC, Falk PM, Frank AL, et al. F-18 fluorodeoxyglucose (FDG) PET for preoperative staging of colorectal carcinoma (abstr). J Nucl Med 1992;33:975.
16. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 Fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998;206:755-60.
17. Mukai M, Sadahiro S, Yasuda S, et al. Preoperative evaluation by wholebody 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep 2000;7:85-87.
18. Kantorová I, Lipská L, Bělohlávek O, et al. Routine 18F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003;44:1784-8.
19. Arulampalam THA, Costa DC, Loizidou M, et al. Positron emission tomography and colorectal cancer. Br J Surg 201, 88:176-89.
20. Thoeni RF. Colorectal cancer: radiological staging. Radiol Clin N Am 1997;35:457-8.
21. Hundt W, Braunschweig R, Reiser M. Evaluation of spiral CT in staging of colon and rectum carcinoma. Eur J Radiol 1999;9:78-84.
22. Angelelli G, Macarini L, Lupo L, et al. Rectal carcinoma: CT staging with water as contrast medium. Radiology 1990;177:511-14.
23. Chiesura-Corona M, Muzzio PC, Giust G, et al. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 2001;26:134-8.
24. Cohade C, Osman M, Leal J, et al. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797-803.
25. Mafsuoka H, Nakamura A, Masaki T, et al. Preoperative staging by multidetector-row computed tomography in patients with rectal carcinoma. Am J Surg 2002;184:131-5.
26. Klinna C, Eibel R, Matzek W, et al. Staging of rectal cancer: diagnostic potential of multiplanar reconstructions with MDCT. AJR Am J Roentgenol 2004;183:421-7.
27. Flippone A, Ambrosini R, Fuschi M, et al. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multidetector-row CT colonography-initial experience. Radiology 2004;231:83-90.
28. Boykin KN, Zibari GB, Lilien DL, et al. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 1999;65:1183-5.
29. Ruers TJ, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with (F-18)fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-95.